AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 47 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $73,000 | -8.8% | 21,553 | +9.3% | 0.00% | – |
| Q4 2017 | $80,000 | +471.4% | 19,722 | -14.4% | 0.00% | – |
| Q3 2017 | $14,000 | +16.7% | 23,043 | +0.2% | 0.00% | – |
| Q2 2017 | $12,000 | -36.8% | 22,987 | -6.5% | 0.00% | – |
| Q1 2017 | $19,000 | -17.4% | 24,591 | +0.2% | 0.00% | – |
| Q4 2016 | $23,000 | +27.8% | 24,530 | +0.8% | 0.00% | – |
| Q3 2016 | $18,000 | -14.3% | 24,340 | +50.2% | 0.00% | – |
| Q2 2016 | $21,000 | -36.4% | 16,207 | +9.4% | 0.00% | – |
| Q1 2016 | $33,000 | -70.0% | 14,821 | +1.5% | 0.00% | – |
| Q1 2015 | $110,000 | +124.5% | 14,606 | +2.8% | 0.00% | – |
| Q4 2014 | $49,000 | -75.1% | 14,215 | -39.6% | 0.00% | – |
| Q2 2014 | $197,000 | +26.3% | 23,534 | -4.0% | 0.00% | – |
| Q1 2014 | $156,000 | +19.1% | 24,510 | +33.6% | 0.00% | – |
| Q4 2013 | $131,000 | +1.6% | 18,344 | +7.0% | 0.00% | – |
| Q3 2013 | $129,000 | +31.6% | 17,146 | +1.2% | 0.00% | – |
| Q2 2013 | $98,000 | – | 16,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Shilanski & Associates, Inc. | 937,237 | $57,000 | 0.02% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $57,000 | 0.02% |
| CVA Family Office, LLC | 1,137,920 | $69,000 | 0.02% |
| Cypress Capital Management LLC (WY) | 140,925 | $9,000 | 0.01% |
| Helen Stephens Group, LLC | 117,222 | $7,000 | 0.01% |
| COURIER CAPITAL LLC | 540,056 | $33,000 | 0.00% |
| NORTHCAPE WEALTH MANAGEMENT, LLC | 98,000 | $6,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 10,000 | $1,000 | 0.00% |
| Western Wealth Management, LLC | 352,950 | $11,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 606,800 | $37,000 | 0.00% |